USA – Epinephrine and morphine added to FDA’s COVID-19 compounding lists

Two more injectable medications have been added to the US Food and Drug Administration’s (FDA) guidances on drugs that can be compounded by registered outsourcing facilities and some smaller compounders if they are used for patients hospitalized with the novel coronavirus COVID-19.

The addition of epinephrine and morphine sulfate to the guidances brings the total number of drugs listed to 15. Most of the medications are anesthetics or analgesics that support mechanically ventilated patients, though furosemide, a cardiovascular drug, and vancomycin hydrochloride, an antibiotic, are also on the list…